JPM 2026 Briefing: Life Sciences Expansion Meets AI, Trade, and China Data Governance
A Hogan Lovells panel at the 2026 J.P. Morgan Healthcare Conference highlights that international expansion in life sciences is increasingly shaped by AI regulation, trade controls, and supply-chain security. The discussion points to faster PRC approval pathways alongside tighter data/genetic governance, and rising scrutiny of tariffs and country-of-origin representations in the U.S. and EU.